| ESVC – European Society of Veterinary Cardiology |
| ESVC-P-1 |
Flanders |
Machine learning and directed δ-QRS vector programming for the differentiation of posterior and anterior accessory pathways in dogs with preexcitation |
| ESVC-P-2 |
Padrosa Sala |
Validation of an artificial intelligence tool for automatic recognition of pulmonary artery and aorta velocities |
| ESVC-P-3 |
Chen |
Clinical characteristics, echocardiographic findings, and computed tomography angiography in the diagnosis of sinus venosus atrial septal defect with partial anomalous pulmonary venous connections in ten dogs |
| ESVC-P-4 |
van de Watering |
Echocardiographic assessment of shunt flow characteristics to evaluate hemodynamic relevance of left-to-right patent ductus arteriosus in dogs |
| ESVC-P-5 |
Seu |
Comparison of different echocardiographic methods to identify left ventricular concentric hypertrophy in dogs with pressure overload |
| ESVC-P-6 |
Valeri |
Left atrioventricular coupling index: an echocardiographic index of atrioventricular disfunction in dogs with myxomatous mitral valve disease |
| ESVC-P-7 |
Valente |
Prognostic value of plasmatic dimethylarginines in dogs with myxomatous mitral valve disease |
| ESVC-P-8 |
Dossi |
Myocardial injury in cats with blunt trauma |
| ESVC-P-9 |
Guyon |
Ultrasound-guided microwaves ablation of heart base tumors in 9 dogs: preliminary outcomes (2022-2025) |
| ESVC-P-10 |
Colasse |
Retrospective study of the prevalence of transient phenotypes in cats with cardiomyopathy |
| ESVC-P-11 |
Iwasa |
Effect of serum fibroblast growth factor-23 concentration in dogs with myxomatous mitral valve disease |
| ESVC-P-12 |
Kim |
Disease stage-related electrolyte imbalances in treatment-naive maltese dogs with myxomatous mitral valve disease: do they predict outcome? |
| ESVC-P-13 |
Baisan |
Left atrial dimension and function in cats with congestive heart failure with or without aortic thromboembolism secondary to hypertrophic cardiomyopathy |
| ESVC-P-14 |
Grosso |
The Mitral Insufficiency Clinical Severity (MICS) score: a severity classification based on physical examination in dogs with myxomatous mitral valve diseases |
| ESVC-P-15 |
Caro-Vadillo |
Mitral valve velocities and tissue doppler velocities in dogs with degenerative mitral valve disease: are B2 dogs all the same? |
| ESVC-P-16 |
Seo |
Changes in left heart dimensions in non-purebred cats with or without hypertrophic cardiomyopathy |
| ESVC-P-17 |
Cimerman |
The bacterial gut microbiota and its association with peripheral blood immune cell populations in myxomatous mitral valve disease in dogs |
| ESVC-P-18 |
Cimerman |
Associations between peripheral blood immune cells, cytokines, chemokines, inflammatory blood markers and echocardiographic variables in canine myxomatous mitral valve disease |
| ESVC-P-19 |
Serres |
Use of BimodVet device for the quantitative assessment of heart murmur severity in dogs with mitral valve disease |
| ESVC-P-20 |
Monge-Utrilla |
Proposed adaptation of Carpentier's mitral regurgitation classification from human to veterinary |
| SCH – Society of Comparative Hepatology |
| SCH-P-1 |
Specchia |
Establishment of an inferred reference range for blood ammonia in dogs and cats using a point-of-care assay |
| SCH-P-2 |
Zoia |
Clinical implications of hepatic volume and shunt morphology in dogs with congenital portosystemic shunts and the impact of attenuation on volume based on shunt type |
| SCH-P-3 |
Dini |
Hydrosoluble vitamins (riboflavin, niacin, pantothenic acid) in dogs with chronic liver disease and healthy controls |
| ESVNU – European Society of Veterinary Nephrology and Urology |
| ESVNU-P-1 |
Luckschander-Zeller |
In practice experiences challenging the superiority of symmetric dimethylarginine over creatinine as an indicator of decreased glomerular filtration rate in a cat population of 259 individuals with various disease entities |
| ESVNU-P-2 |
Dinkel |
Retrospective analysis of the prevalence of different types of uroliths in the lower urinary tract in dogs and cats in Southwestern Germany |
| ESVNU-P-4 |
Navarro |
Serum versus urinary kidney injury molecule-1: comparative biomarker assessment in a population of dogs with chronic kidney disease in Spain |
| ESVNU-P-5 |
Bujok |
Changes in the activity of intestinal microbiota in cats with chronic kidney disease |
| ESVNU-P-6 |
Vercelli |
Antibiotic stewardship to manage canine and feline acute urinary tract infection targeting the use of antibiotics to reduce relapse and antimicrobial resistance |
| ESVNU-P-7 |
Lee |
Molecular prevalence of urinary pathogens in dogs and cats: A retrospective study (2021–2024) |
| ESVNU-P-8 |
Batard |
Clinical efficacy and safety of a medicated diet containing benazepril in cats with chronic kidney disease compared to Fortekor® tablets |
| ESVNU-P-9 |
Tang |
Risk factors associated with progression of chronic kidney disease in cats |
| ESVNU-P-10 |
Hélier |
Urolithiasis in cats : a retrospective study of 4,705 feline urinary calculi collected from 2016 to 2021 in France and analysed by infrared spectrometry |
| ESVNU-P-11 |
Dreller |
Operator-dependent performance of two bacterial in-house culture systems for the diagnosis of canine urinary tract infection |
| ESVNU-P-12 |
Lunet Marques |
Characterization of plasma and urine metanephrines in healthy cats, cats with chronic kidney disease and cats with non-adrenal and non-kidney-related chronic disease |
| ESVNU-P-13 |
Shield |
Effect of daily supplementation of a veterinary formulated liquid hydration supplement on survival and clinical outcomes in 41 cats with chronic kidney disease |
| ESVNU-P-14 |
Monroig Carbonell |
Ultrasonographic Findings in Dogs and Cats with Normal and Elevated Symmetric dimethylarginine Levels |
| ESVNU-P-15 |
Lin |
Evaluation of urinary cystatin B levels in dogs and cats with chronic kidney disease and their relationships with clinical variables and abnormal renal imaging |
| ESVNU-P-16 |
Fernandez Gallego |
Comparison of faecal metabolome in cats with chronic kidney disease and healthy controls before and after supplementation with an indol-binder |
| ESVNU-P-17 |
Postic |
Evaluation of the diagnostic performances of urine dipstick test for detection of borderline and overt proteinuria in cats |
| ESVNU-P-18 |
Grady |
Assessment of gastrointestinal lesions in canine chronic kidney disease: A prospective, observational study |
| ESVNU-P-19 |
Pohlmann |
In vitro susceptibility of antimicrobial resistant strains of Escherichia coli isolated from the urine of dogs to pivmecillinam and fosfomycin |
| ESVNU-P-20 |
Westropp |
Stability of urine sediment elements in specimens from dogs stored at -80°C as assessed by manual microscopy and digital microscopy artificial intelligence algorithm |
| ESVNU-P-21 |
Lund |
Effect of castration in dogs with androgen dependent cystine urolithiasis |
| ESVCP - European Society of Veterinary Clinical Pathology |
| ESVCP-P-1 |
Eiermann |
Impact of treadmill running on circulating cortisol concentrations in clinically healthy dogs |
| ESVCP-P-2 |
Gil |
Correlation between hematological parameters and thromboelastographic alterations in dogs |
| ESVCP-P-3 |
Gach |
Histopathological and immunohistochemical analysis of chordae tendineae degeneration in dogs |
| ESVCP-P-4 |
Villanueva-López |
Assessing the suitability of long-term serum preservation for research: impact of storage duration and temperature on anti-leishmania antibody detection in canine serum samples |
| ESVCP-P-5 |
Zoia |
Comparing the diagnostic utility of simplified Boyer’s criteria and two veterinary classification systems, Stockham & Scott 2008 and eClinPath-Stokol 2014, in discriminating transudates from exudates in dogs with ascites |
| ESVCP-P-6 |
Zoia |
External validation of the simplified Boyer’s criteria and the Zoia et al. algorithm for classifying ascites in canine patients |
| ESVCP-P-7 |
Tamborini |
Association between platelet count, platelet indices and other cell lines counts |
| ESCG – European Society of Comparative Gastroenterology |
| ESCG-P-1 |
Puccinelli |
Ultrasonographic features and clinical relevance of Peyer’s patches in dogs |
| ESCG-P-2 |
Nivy |
Efficacy and tolerability of gelatin tannate (Tasectan®) in dogs naturally infected with canine parvovirus |
| ESCG-P-4 |
Cerquetella |
Fecal proteome profile in clinically healthy dogs fed bone and raw food or kibble diet |
| ESCG-P-5 |
Grønvold-Barry |
Investigation of cobalamin levels in dogs with acute haemorrhagic diarrhoea syndrome |
| ESCG-P-6 |
Cridge |
Establishment and characterization of canine pancreatic organoids & organoid-derived monolayers |
| ESCG-P-7 |
Cridge |
Investigation into and analytical validation of a microRNA panel for suspected pancreatitis in dogs |
| ESCG-P-8 |
Doulidis |
Molecular footprints of inflammation and metabolic dysregulation in the plasma of dogs with parvoviral enteritis |
| ESCG-P-9 |
Lloyd-Bradley |
Assessing faecal Granzyme B activity as a marker of intestinal inflammation in dogs |
| ESCG-P-10 |
Simpson |
Serum metabolomic analysis of cats with chronic enteropathies |
| ESCG-P-11 |
Romano |
Evaluation of the impact of proton pump inhibitors on serum and fecal biomarkers associated with intestinal dysbiosis in healthy dogs |
| ESCG-P-12 |
Oggiano |
Development and validation of a quality of life questionnaire for dogs with chronic enteropathy |
| ESCG-P-13 |
Baum |
Long-term effect of a past episode of acute hemorrhagic diarrhea on gastrointestinal clinical signs and fecal metabolites in dogs |
| ESCG-P-14 |
Juárez Sarrión |
Evaluation of prognostic markers in 192 dogs hospitalized with a suspected diagnosis of acute pancreatitis in a referral center in Spain |
| ESCG-P-15 |
Maufras |
Towards a better understanding of clinical disease activity scores in dogs with chronic enteropathies |
| ESCG-P-16 |
Pilla |
Fecal microbiome of wolves and wolfdogs in comparison with pet dogs |
| ESCG-P-17 |
Grellet |
Description of a Golden Retriever Cohort: an open science study to better characterize the first days of life and their short, medium and long-term consequences in dogs |
| ESCG-P-19 |
Ingram |
The core fecal microbiota of healthy adult dogs is composed of 50 genera based on amplicon sequencing |
| ESCG-P-20 |
Ingram |
Disruption of the Canine Fecal Microbiota Reveals Distinct Patterns of Dysbiosis Across Disease States |
| ESCG-P-21 |
Winston |
Fecal microbiota transplantation from lean dogs to obese dogs shifts the microbiome and leads to long-term engraftment |
| ESCG-P-22 |
Schmidt |
The fecal microbiome and bile acid metabolism in feline chronic kidney disease |
| ESCG-P-23 |
Caulfield |
Long-term outcome of chronic inflammatory enteropathy in 61 dogs |
| ESCG-P-24 |
Crisi |
Hematological ratios and biochemical parameters as supportive markers for differentiating feline chronic enteropathy |
| ESCG-P-25 |
Pitropaki |
Effects of a dietary supplement containing olive polyphenols on specific gut microorganisms in military dogs |
| ESCG-P-26 |
Weidinger |
Antibiotic-induced changes in the fecal microbiome of young dogs |
| ESCG-P-27 |
Pongrac |
Diagnostic utility of urinary lipase DGGR (1,2-o-dilauryl-rac-glycero-3- glutaric acid-(6′-methylresorufin) ester) and its creatinine clearance ratio in acute pancreatitis |
| ESCG-P-28 |
Andreatta |
Beyond diarrhea: clinical impact of fecal microbiota transplantation |
| ESCG-P-29 |
Cocci |
Predictors of dietary response and long-term follow-up in canine protein-losing enteropathy: a retrospective study in 34 dogs (2022–2025) |
| ESCG-P-30 |
Suchodolski |
Fecal dysbiosis index, bile acids and calprotectin in dogs with tylosin-responsive enteropathy receiving fecal microbiota transplantation |
| ESVIM – European Society of Veterinary Internal Medicine |
| ESVIM-P-2 |
Berro |
Usefulness of serum amyloid A to differentiate feline inflammatory lower respiratory tract disease from other respiratory conditions: A retrospective study of 22 cats (2021-2024) |
| ESVIM-P-3 |
Lodarski |
Utility of diagnostic investigations in dogs with pyrexia |
| ESVIM-P-4 |
Carrasco |
The use of leflunomide in cats with immune-mediated anaemia |
| ESVIM-P-5 |
Chen |
The clinical utility of the antinuclear antibody test in dogs |
| ESVIM-P-6 |
Pavlin |
New therapeutic drug inducing degradation of tau aggregates elicits long-term clinical improvement in canine cognitive dysfunction |
| ESVIM-P-7 |
Carrasco |
Thrombocytopenia in dogs in the Mediterranean area: a retrospective study |
| ESVIM-P-8 |
Kulmer |
Comparison of prednisolone alone versus cyclosporine A combined with prednisolone in cats with primary immune-mediated hemolytic anemia in respect to outcome, duration of treatment and adverse effects |
| ESVIM-P-9 |
McDonnell |
Retrospective evaluation of haematological ratios in dogs with immune thrombocytopenia: 87 cases |
| ESVIM-P-10 |
Molins Torrades |
Primary erythrocytosis in 57 dogs: a multicentric retrospective study |
| ESVIM-P-11 |
Hukkinen |
Antimicrobial peptides in bronchoalveolar lavage fluid of Irish Wolfhounds with recurrent bacterial pneumonia |
| ESVIM-P-12 |
Tirelli |
Clinical application and agreement of anti-erythrocyte antibodies measured by flowcytometry and direct antiglobulin test (Coomb’s test) in cats with anemia |
| ESVIM-P-13 |
Dini |
Effect of blood donation on serum cobalamin and folic acid concentrations in dogs |
| ESVIM-P-14 |
Emming |
Impact of culture-based microbiological examination on diagnosis and treatment in cats with chronic nasal disease |
| ESVIM-P-15 |
Tellier |
Laryngeal disease in cats: A retrospective single-center study of 20 cases (2020 – 2024). |
| ESVIM-P-16 |
Molins Torrades |
Primary erythrocytosis in 37 cats: a multicentric retrospective study. |
| ESVIM-P-17 |
Bernard |
Hypokalemia in dogs diagnosed with immune-mediated hemolytic anemia: a retrospective study of 44 cases |
| ESVIM-P-19 |
Foo |
Retrospective evaluation of dogs presented with severe single limb swelling in two referral centres |
| ESVIM-P-20 |
Ogallar Arcos |
Primary immune-mediated thrombocytopenia in five Maltese dogs: clinical data, clinicopathologic findings, and short- and long-term outcomes |
| ESVONC – European Society of Veterinary Oncology |
| ESVONC-P-1 |
Dollansky |
Vector-borne infections in dogs with canine transmissible venereal tumor |
| ESVONC-P-2 |
Schils |
Study of Fibroblast Activation Protein expression in canine gastric carcinoma |
| ESVONC-P-4 |
Ivanovs |
A survey exploring measures taken by referral practitioners to reduce the risk of cyclophosphamide induced sterile haemorrhagic cystitis |
| ESVONC-P-5 |
Nicolás |
Evaluation of heart fatty acid-binding protein as an early diagnostic biomarker of doxorubicin-induced cardiotoxicity in dogs |
| ESVONC-P-6 |
Killick |
Breed predispositions for dog with squamous cell carcinoma at different anatomical sites in the UK |
| ESVONC-P-8 |
Tavares |
Malignancy and epidemiology of adrenal tumors in dogs |
| ESVONC-P-9 |
Dini |
Elevated serum gammaglutamyl-transferase in nine dogs with dogs with hemopoietic tumors: a new paraneoplastic clinicopathological manifestation |
| ISCAID – International Society for Companion Animal Infectious Diseases |
| ISCAID-P-1 |
Borras |
Brucella canis infection in dogs in Buenos Aires, Argentina: A retrospective multicentric study of 25 cases |
| ISCAID-P-2 |
Jaffey |
Diagnostic sensitivity of polymerase chain reaction to detect Coccidioides spp. in oropharyngeal, nasal, and conjunctival swab samples in dogs with newly diagnosed pulmonary coccidioidomycosis |
| ISCAID-P-3 |
Theron |
Evaluation of the prognostic value of C - reactive protein and blood parameters in dogs with spontaneous Angiostrongylus vasorum infection |
| ISCAID-P-4 |
An |
Canine respiratory pathogens in South Korea: real-time polymerase chain reaction-based epidemiology from 4,975 cases |
| ISCAID-P-5 |
Andrijasevic |
Mortality in cats with feline infectious peritonitis treated with Remdesivir/GS-441524 – should we consider viral sepsis? |
| ISCAID-P-6 |
Schäfer |
Retrospective analysis of a southern European feline travel profile in 661 cats living in Germany |
| ISCAID-P-7 |
Schäfer |
Clinical suspicion of in-vivo resistance against allopurinol in five dogs infected with Leishmania infantum associated with a reduction in copy numbers of the S-adenosylmethionine synthetase gene |
| ISCAID-P-8 |
Humak |
Detection of canine intestinal parasites in Italy by assessing commercial coproantigen immunoassay and Mini-FLOTAC |
| ISCAID-P-9 |
Monroig Carbonell |
Comparison of reticulocyte hemoglobin content in healthy dogs and dogs with leishmaniosis: clinical implications and prognostic value in the disease |
| ISCAID-P-10 |
Remmel |
Evaluation of the usefulness of plasma procalcitonin, serum alpha-1-acid glycoprotein and serum amyloid A in the diagnostic approach of inflammatory diseases in cats: preliminary results. |
| ISCAID-P-11 |
Crimi |
Antimicrobial resistance patterns of cutaneous sample in companion animals in northwestern Italy from 2013 to 2023 |
| ISCAID-P-12 |
Grellet |
Relationship between hygiene practices in breeding catteries and kennels on gastrointestinal parasite infestation |
| ISCAID-P-15 |
Carrasco-Martin |
Clinical application of genomic drug-resistance biomarker detection in canine leishmaniosis |
| ISCAID-P-16 |
Zoia |
Correlation between bone marrow qPCR load and serum globulin, electrophoresis gamma-globulin, serum IgG and IgM, serum creatinine, and urine protein creatinine ratio at diagnosis in dogs with canine leishmaniasis. |
| ISCAID-P-18 |
Danieli |
Antimicrobial resistance in surgical and bite wounds in dogs and cats: a retrospective analysis |
| ISCAID-P-20 |
Amadori |
What can we understand from bacteria isolates and susceptibility testings from prosthesis removal in companion animals? |
| ISCAID-P-21 |
Hartmann |
Measurement of circulating immune complexes and correlation with disease signs in dogs with Leishmania infantum infection in a non-endemic country |
| ISCAID-P-22 |
Amadori |
Retrospective analysis of bacterial isolates and antimicrobial susceptibility patterns from genital swabs of companion animals |
| ISCAID-P-23 |
Amadori |
Antimicrobial resistance patterns of commonly isolated respiratory bacteria in a pet clinic in northwest Italy |
| ISCAID-P-24 |
Beczkowski |
Where do the antibiotics go when they leave the small animal clinic? Investigation of disposal practices of unused veterinary pharmaceuticals worldwide |
| ISCAID-P-25 |
Spiri |
Machine learning as a diagnostic aid for feline infectious peritonitis: A novel approach |
| ESVE – European Society of Veterinary Endocrinology |
| ESVE-P-1 |
Tiefenbrunner |
Management of iatrogenic hypothyroidism in cats following radioiodine treatment using levothyroxine replacement therapy |
| ESVE-P-2 |
Tang |
A predictive algorithm for the optimal daily dosage of thiamazole to stabilise cats with hyperthyroidism |
| ESVE-P-3 |
Nivy |
Hypoglycemia of unknown etiology in Pekingese dogs |
| ESVE-P-4 |
Galdhar |
Studies on neuromuscular clinical manifestation in canine hypothyroidism |
| ESVE-P-5 |
Kraai |
Clinical characteristics, management and survival of dogs with insulinoma under UK primary veterinary care: 278 cases |
| ESVE-P-6 |
Flanagan |
Association between prior obesity and development of feline diabetes mellitus: a pair-matched 1:3 case-control study |
| ESVE-P-7 |
Viau |
Urinary catecholamines in dogs using liquid chromatography and mass spectrometry: first Brazilian validation and diagnostic application for pheochromocytoma |
| ESVE-P-8 |
Bock |
Chronic enteropathy and dysbiosis in dogs with hypoadrenocorticism |
| ESVE-P-9 |
Lecot |
Predictive factors of remission in feline diabetes mellitus: a prospective study |
| ESVE-P-10 |
Rodrigues |
Urinary cortisol to creatinine ratio as a monitoring tool for cortisol levels in dogs with hypoadrenocorticism under replacement therapy |
| ESVE-P-11 |
Gostelow |
Effect of 12-week, intentional caloric restriction, using a novel feline diabetic therapeutic diet, on clinical signs and quality of life in overweight cats with diabetes mellitus: An International prospective, randomized clinical trial |
| ESVE-P-12 |
Fidanzio |
A retrospective comparison of survival time in dogs with adrenal tumors treated with adrenalectomy and not treated with adrenalectomy |
| ESVE-P-13 |
Abas |
Emergency presentations associated with canine hypothyroidism in referral veterinary care in the United Kingdom: a retrospective, cross-sectional study |
| ESVE-P-14 |
van den Berg |
Prognostic value of the Ki67 proliferation index and a histopathological scoring system in dogs with pheochromocytoma undergoing adrenalectomy |
| ESVE-P-15 |
Miceli |
Long-term treatment with cabergoline for feline hypersomatotropism: comorbidities, follow-up and survival time |
| ESVCN – European Society of Veterinary Comparative Nutrition |
| ESVCN-P-1 |
Bela |
Effects of in vitro fermentation of ZT455C versus Carobin in modulating canine gut microbiota and short chain fatty acids production |
| ESVCN-P-3 |
Zentek |
Immunological response to poultry protein, legumes, wheat and quinoa in diets for dogs |
| ESVCN-P-4 |
Faurot |
Potassium citrate significantly increases urine pH in healthy adult cats |
| ESVCN-P-5 |
Navarro |
Long-term adherence to a canine weight loss plan: impact on body condition, blood parameters, and quality of life |
| ESVCN-P-6 |
Bjørnvad |
Twelve-week, intentional caloric restriction, with a novel therapeutic feline diabetic diet suitable for weight reduction, in overweight diabetic cats results in well-tolerated weight reduction |
